Results and prospects for the use of DPP-4 inhibitor in patients with diabetes mellitus type 2
The incidence of diabetes worldwide is increasing annually, despite all efforts of the global healthcare. Cardiovascular complications remain the main cause of morbidity and mortality in patients with diabetes mellitus type 2.